BIRC5 and cancer: Indeed, from the point of view of anticancer therapy, the multiple functions performed by survivin in molecular processes that are typically altered in cancer cells suggest that targeting survivin may be advantageous compared with targeting other molecules involved in a single oncogenic pathway [98].